DUSA Pharmaceuticals, Inc. (DUSA) Tops Q4 EPS by 3c
Tweet
Share
E-mailGet Alerts DUSA Hot Sheet
Price: $56.86 +0.55%
Financial Fact:
BASIC NET INCOME (LOSS) PER COMMON SHARE: -0.06
Today's EPS Names:
ANAB, ANIX, MNY, More
Financial Fact:
BASIC NET INCOME (LOSS) PER COMMON SHARE: -0.06
Today's EPS Names:
ANAB, ANIX, MNY, More
Join SI Premium – FREE
DUSA Pharmaceuticals, Inc. (NASDAQ: DUSA) reported Q4 EPS of $0.16, $0.03 better than the analyst estimate of $0.13. Revenue for the quarter came in at $15.3 million versus the consensus estimate of $13.84 million.
For earnings history and earnings-related data on DUSA Pharmaceuticals, Inc. (DUSA) click here.
For earnings history and earnings-related data on DUSA Pharmaceuticals, Inc. (DUSA) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron offers Taiwan workers up to 68-month bonuses as strike threat looms
- Investing.com’s stocks of the week
- GE Vernova (GEV) PT Raised to $1,185 at Jefferies
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
